Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer

Jones, L; Hawkins, N; Westwood, M; Wright, K; Richardson, G; Riemsma, R; (2004) Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. Health technology assessment (Winchester, England), 8 (5). iii, xiii-xvi, 1-143. ISSN 1366-5278 http://researchonline.lshtm.ac.uk/id/eprint/2534908

Permanent Identifier

Use this permanent URL when citing or linking to this resource.

http://researchonline.lshtm.ac.uk/id/eprint/2534908

Abstract

Share

Download

Filename: Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine Xeloda for locally advanced andor metastatic breast cancer.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Google Scholar